Adiponectin

Adiponectin improves glucose and lipid metabolism and enhances insulin sensitivity. Higher adiponectin is associated with lower cardiovascular risk, lower insulin resistance, and better fat oxidation capacity. Rising adiponectin supports a feedback loop that favors fat reduction. Regular moderate fasted aerobic activity can increase plasma adiponectin over 8 to 12 weeks through AMPK and PPAR gamma signaling. Reducing visceral fat to normalize adiponectin production is described as an effective strategy for preventing type 2 diabetes and cardiovascular disease. Consistent fasted walking may produce measurable changes in fasting insulin, adiponectin profile, and waist circumference by week 12. Adiponectin is a beneficial hormone released by healthy fat tissue. Adiponectin is a hormone produced by adipose tissue that improves insulin sensitivity and helps block inflammation, but its levels decrease paradoxically as visceral fat increases. Macrophage infiltration and local inflammation in expanded visceral fat suppress adiponectin gene expression in adipocytes. Adiponectin is a fat-cell hormone, produced more by subcutaneous fat than visceral fat, that improves insulin sensitivity and…